Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zestfol is a nutritional supplement marketed by DWD Pharmaceuticals, primarily used as a prenatal supplement and for the management of nutritional deficiencies. It contains a combination of L-methylfolate (the active form of folic acid), methylcobalamin (the active form of Vitamin B12), and pyridoxal 5-phosphate (the active form of Vitamin B6). These components are critical for DNA synthesis, red blood cell formation, and the regulation of homocysteine levels. By providing the active forms of these vitamins, Zestfol ensures optimal bioavailability, which is particularly beneficial for individuals with metabolic variations such as MTHFR gene polymorphisms. It is commonly prescribed during pregnancy to prevent neural tube defects and to support overall fetal development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zestfol.